Cycloserine for treatment of multidrug-resistant tuberculosis: a retrospective cohort study in China

PURPOSE: Cycloserine has been used in multidrug-resistant tuberculosis (MDR-TB) treatment since the 1950s. We evaluated the efficacy and safety of cycloserine and sought to clarify the role of cycloserine for treatment of simple MDR-TB, pre-extensively drug-resistant tuberculosis (pre-XDR-TB), and e...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Infect Drug Resist
Glavni autori: Li, Yang, Wang, Fei, Wu, Limin, Zhu, Min, He, Guiqing, Chen, Xinchang, Sun, Feng, Liu, Qihui, Wang, Xiaomeng, Zhang, Wenhong
Format: Artigo
Jezik:Inglês
Izdano: Dove Medical Press 2019
Teme:
Original Research
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6445236/
https://ncbi.nlm.nih.gov/pubmed/30992677
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/IDR.S195555
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items